Kurt Shanebeck

5.1k total citations · 4 hit papers
21 papers, 4.3k citations indexed

About

Kurt Shanebeck is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Kurt Shanebeck has authored 21 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Oncology. Recurrent topics in Kurt Shanebeck's work include Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Kurt Shanebeck is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Kurt Shanebeck collaborates with scholars based in Canada, United States and United Kingdom. Kurt Shanebeck's co-authors include Judith G. Giri, Kenneth H. Grabstein, Dirk Anderson, Minoo Ahdieh, June Eisenman, Satoru Kumaki, David Cosman, Mark R. Alderson, A E Namen and M A Schoenborn and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Kurt Shanebeck

21 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor

1994 1.2k citations Kenneth H. Grabstein, June Eisenman et al. Science profile →
Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.

1994 872 citations Judith G. Giri, Minoo Ahdieh et al. The EMBO Journal profile →
Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor.

1995 542 citations Judith G. Giri, Satoru Kumaki et al. The EMBO Journal profile →
Interleukin 1 signaling occurs exclusively via the type I receptor.

1993 503 citations John E. Sims, Margit Gayle et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Kurt Shanebeck

Since Specialization

Citations

This map shows the geographic impact of Kurt Shanebeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Shanebeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Shanebeck more than expected).

Fields of papers citing papers by Kurt Shanebeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Shanebeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Shanebeck. The network helps show where Kurt Shanebeck may publish in the future.

Co-authorship network of co-authors of Kurt Shanebeck

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Shanebeck. A scholar is included among the top collaborators of Kurt Shanebeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Shanebeck. Kurt Shanebeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1101 ASKG315 – an IL-15 prodrug with antibody-Like PK, enhanced safety and expanded therapeutic window 2022 ·Regular and Young Investigator Award Abstracts ·(unknown), Kurt Shanebeck, (unknown), Chao Wang, Shiguang Yu, (unknown), Ray Y. Chuang, Ming Li, (unknown), Jeff Zhiqiang Lu, Yuefeng Lu	2
2	1183 ASKG915 – an anti-PD-1 antibody-IL-15 prodrug fusion molecule with enhanced therapeutic potentials 2022 ·Regular and Young Investigator Award Abstracts ·Kurt Shanebeck, (unknown), Shiguang Yu, (unknown), Dongfang Wang, (unknown), Ming Li, Ray Y. Chuang, Jing Chen, (unknown), (unknown), Stone D.‐H. Shi, (unknown), (unknown), Jeff Zhiqiang Lu, Yuefeng Lu	6
3	Abstract 693: ASKG843, a bifunctional fusion protein of PD1/TGF-βRII, demonstrates potent in vitro/in vivo activities, and excellent pharmacokinetic properties in non-human primates (NHPs) with good safety profiles 2021 ·Cancer Research ·Liqin Liu, Shiwen Zhang, Kurt Shanebeck, (unknown), Yunxia Yuan, Ming Li, Lu Li, Ray Y. Chuang, (unknown), Yuefeng Lu, Jeff Zhiqiang Lu	1
4	AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use—improves psoriasis in a human xenograft transplantation model 2015 ·Protein Engineering Design and Selection ·Karin Stenderup, Cecilia Rosada, Kurt Shanebeck, William Brady, (unknown), Gordon J. King, Marcello Marelli, (unknown), Hengyu Xu, (unknown), Jeffrey Johnson, (unknown), Gary Li, (unknown), Tomas Norman Dam, Kenneth H. Grabstein	14
5	Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody–Drug Conjugates Using Click Cycloaddition Chemistry 2015 ·Bioconjugate Chemistry ·(unknown), Kurt Shanebeck, Zachary Caldwell, Jeffrey Johnson, Pamela Thompson, (unknown), Huifang Dong, Gary Li, Hengyu Xu, François D’Hooge, Luke A. Masterson, Pauline A. Bariola, Arnaud Tiberghien, (unknown), David G. Williams, John A. Hartley, Philip W. Howard, Kenneth H. Grabstein, Michael A. Bowen, Marcello Marelli	105
6	Development of Copper-Catalyzed Azide–Alkyne Cycloaddition for Increased in Vivo Efficacy of Interferon β-1b by Site-Specific PEGylation 2012 ·Bioconjugate Chemistry ·(unknown), Kurt Shanebeck, Aijun Wang, Thomas J. Graddis, (unknown), (unknown), Kenneth H. Grabstein	28
7	Variable expression of immunoreactive surface proteins of Propionibacterium acnes 2006 ·Microbiology ·Michael J. Lodes, Heather Secrist, Darin R. Benson, (unknown), Kurt Shanebeck, Jeffrey A. Guderian, Jean-François Maisonneuve, Ajay Bhatia, David H. Persing, Sheila Patrick, Yasir A. W. Skeiky	55
8	IFN-^γis a potent inducer of Ig secretion by sort-purified murine B cella activated through the mlg, but not the CD40,signaling pathway 1996 ·International Immunology ·Clifford M. Snapper, F R Rosas, Mark A. Moorman, Liang Jin, Kurt Shanebeck, Dennis M. Klinman, Marilyn R. Kehry, James J. Mond, Charles R. Maliszewski	34
9	Regulation of murine B cell growth and differentiation by CD30 ligand 1995 ·European Journal of Immunology ·Kurt Shanebeck, (unknown), Mary K. Kennedy, Kathleen S. Picha, Craig A. Smith, (unknown), Kenneth H. Grabstein	65
10	Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. 1994 ·The Journal of Immunology ·Judith G. Giri, Jerry M. Wells, Steven Dower, Charles E. McCall, (unknown), Jennifer L. Slack, Timothy A. Bird, Kurt Shanebeck, K H Grabstein, John E. Sims, (unknown)	123
11	Induction of B cell costimulatory function by recombinant murine CD40 ligand 1994 ·European Journal of Immunology ·Mary K. Kennedy, Kendall M. Mohler, Kurt Shanebeck, Peter Baum, Kathleen S. Picha, (unknown), Charles A. Janeway, Kenneth H. Grabstein	126
12	Interleukin‐12 regulates the proliferation of Th1, but not Th2 or Th0, clones 1994 ·European Journal of Immunology ·Mary K. Kennedy, Kathleen S. Picha, Kurt Shanebeck, Dirk Anderson, Kenneth H. Grabstein	111
13	Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor breakdown → 1994 ·Science ·Kenneth H. Grabstein, June Eisenman, Kurt Shanebeck, Charles T. Rauch, Subhashini Srinivasan, Victor Fung, Courtney Beers, Jane S. Richardson, M A Schoenborn, Minoo Ahdieh, (unknown), Mark R. Alderson, James D. Watson, Dirk Anderson, Judith G. Giri	1234
14	A novel T cell factor IL-15, shares both the beta and gamma subunits of the IL-2 receptor 1994 ·Cytokine ·Judith G. Giri, Kenneth H. Grabstein, (unknown), June Eisenman, Ray Paxton, Kurt Shanebeck, Linda Park, Satoru Kumaki, David Cosman, Dirk Anderson	7
15	Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. breakdown → 1994 ·The EMBO Journal ·Judith G. Giri, Minoo Ahdieh, June Eisenman, Kurt Shanebeck, Kenneth H. Grabstein, Satoru Kumaki, A E Namen, (unknown), David Cosman, Dirk Anderson	872
16	The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2 1993 ·The Journal of Immunology ·K H Grabstein, C R Maliszewski, Kurt Shanebeck, Takaaki Sato, Melanie K. Spriggs, William C. Fanslow, Richard J. Armitage	80
17	Interleukin 1 signaling occurs exclusively via the type I receptor. breakdown → 1993 ·Proceedings of the National Academy of Sciences ·John E. Sims, Margit Gayle, Jennifer L. Slack, Mark R. Alderson, Timothy A. Bird, Judith G. Giri, Francesco Colotta, Fabio Re, Alberto Mantovani, Kurt Shanebeck	503
18	Regulation of T cell proliferation by IL-7. 1990 ·The Journal of Immunology ·K H Grabstein, A E Namen, Kurt Shanebeck, (unknown), S G Reed, M B Widmer	89
19	Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma. 1987 ·The Journal of Experimental Medicine ·Steven G. Reed, Carl Nathan, (unknown), (unknown), Kurt Shanebeck, Paul Conlon, Kenneth H. Grabstein	182
20	Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines. 1986 ·The Journal of Experimental Medicine ·Kenneth H. Grabstein, June Eisenman, D Y Mochizuki, Kurt Shanebeck, Paul Conlon, Thomas P. Hopp, Carl J. March, Steven Gillis	161

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact